Choose   Change

picture of BGI laboratory

Immune Repetoire Sequencing


immunoreptorie-sequencingImmune repertoire refers to the sum total of functionally diverse B and T-cells in the circulatory system at any given moment (Wang et al. 2011). The diversity of immune repertoire is of vital importance for health. Immune Repertoire Sequencing (IR-SEQ) is to amplify the complimentary determining region (CDR) of B-cell receptor (BCR) or T-cell receptor (TCR) using multiple-PCR or 5’ RACE methods, followed by high-throughput sequencing. It is used to study the diversity of the immune system and the associations between immune repertoire and diseases.


    • Proprietary methods: we have designed specific primers for CDR3 V region and C region to amplify CDR3 region, and patents for TRA, IGH, and IGK/IGL have been applied successfully.
    • High-fidelity amplification methods: multiple-PCR or 5’ RACE method is used to equivalently amplify different clones and the number of unique clones is as large as 105.
    • Multiple sequencing platforms: Hiseq2000, Hiseq2500 and Roche 454 are available for different project requirements.




1. C. Wang et al. J. Immunol. 186, 65.20 (2011)

Technical Information


High-fidelity and low bias

Two-step library construction method and BGI proprietary primers for lower amplification bias and true T/B cell clone properties.

High repeatability

High consistency between two libraries from one sample (Fig. 1).

Immune Repertoire Repeatibility Evaluation
Flexible services 

The following services are available for human T/B cells

Immune Repertoire Flexible Services
High-resolution analytical pipeline

BGI-developed software “IMonitor” demonstrates better performance in correcting PCR and sequencing errors, and providing more customized bioinformatic analysis.¹

Immune Repertoire High-Resolution Analytical Pipeline


Peripheral blood mononucleated cells (PBMCs) are isolated from peripheral blood, followed by DNA or RNA extraction. Multiple-PCR or 5’RACE method is used to capture CDR3 region (5’ RACE can also capture CDR1 and CDR2), and then the captured region is sequenced on high-throughput platforms (Hiseq2000, Hiseq2500, Miseq or Roche 454).


1. Zhang W, Du Y, et al. (2015). “IMonitor: A Robust Pipeline for TCR and BCR Repertoire Analysis.” Genetics.


Immune Repertoire Case Study

The semi-quantitative results of V b and J b segment usage in blood of liver cancer patients and healthy adults.² (A) V segment usage in blood samples from 20 liver cancer patients. (B) J segment usage in blood samples from 20 liver cancer patients. (C) V segment usage in blood samples from 21 healthy adults. (D) J segment usage in blood samples from 21 healthy adults.

2. Yingxin Han, Xing Liu, et al. (2015). ” Identification of characteristic TRB V usage in HBV-associated HCC by using differential expression profiling analysis.” OncoImmunology.

Request a Quote

Contact form for BGI
  •   Whole Genome Resequencing
      Exome Sequencing
      Target Region Sequencing
      de novo Sequencing
      RNA-Seq (Transcriptome)
      RNA-Seq (Quantification)
      Small RNA Sequencing
      Long Non-coding RNA Sequencing
      Whole Genome Bilsulfite Sequencing
      Reduced Representation Bilsulfite Sequencing
      MeDIP Sequencing
      16S rDNA tagging
      Wole Genome Metagenomic Sequencing
      Microbial Gene Catalog
      Proteomics Services
  •   Human
  •   Yes

Contact USA

Don’t hesitate to contact us to request a quote or to talk more about your requirements and how we can support your needs.

(+45) 80 300 800 (Europe)
(+1) 617 500 2741 (Americas)
(+852) 36103510 (Asia Pacific)
(+86) 755 25273698 (China)

BGI certificates

Copyright © BGI 2016